These drugs do something completely different to lower cholesterol.
Prevent different enzyme, known as the vanguard of protein convertase / Kexin Type 9 or PCSK9. This enzyme ensures that the liver usually do not have a lot of LDL cholesterol from the bloodstream. When the receptor molecule takes the site of LDL from the bloodstream, usually permanently closed as a result of the work of PCSK9. These new drugs, which are antibodies cloned in fact, keep PCSK9 to latch receptor…
Continuar
Publicado el diciembre 1, 2015 a las 12:06am
Muro de comentarios
¡Tienes que ser miembro de I.S.K.A. LATIN AMERICA para agregar comentarios!